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Background
Hereditary angioedema (HAE) is a rare autosomal dominant disease characterized by swelling of the
face, lips, tongue, larynx, genitalia, or extremities, with abdominal pain caused by intra-abdominal
edema. HAE is caused by mutations affecting the C1 inhibitor gene (SERPING1), resulting in low
levels of C1 inhibitor (Type I HAE) or normal levels of ineffective C1 inhibitor (Type II HAE).
Method
Genotyping was performed by means of a targeted next generation sequencing platform of the
SERPING1 in 30 C1-INH-HAE type 1 patients, belonging to 13 HAE families. The newly developed
and validated custom NGS platform targets the entire 11q12-q13.1 loci, including the promoter, coding,
intron-exon boundary as well as intronic regions of the SERPING1 gene. Complement fractions and
clinical symptoms were analyzed in relation to revealed gene mutations. Consent was obtained from all
of the patients.
Results
This is the first genetic study of the Bulgarian HAE patients. Genetic defects were identified in 10 HAE
families are: 3 nonsense, 2 splice-site defects, 2 frameshift mutations, 1 indel non frameshift, 1
missense, and 1 large deletion of exon 4. Novel mutations, not previously reported in human gene
mutation databases were discovered, and were predicted to be deleterious due to the expected effect on
DNA transcript and protein.
Conclusion
We identified 10 mutations of the SERPING1 gene in 13 HAE Type I families form the Bulgarian
population (comprising 50% of the diagnosed HAE families in the country), revealing novel mutations,
causative for C1-INH deficiency. A recently developed and validated targeted NGS platform was used
for SERPING1 genotyping, presenting excellent potential for the future of HAE genetic diagnostics.
